Superstring Capital Management as of June 30, 2026
Portfolio Holdings for Superstring Capital Management
Superstring Capital Management holds 32 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cogent Biosciences (COGT) | 8.4 | $13M | 343k | 38.70 | |
| Axsome Therapeutics (AXSM) | 8.3 | $13M | 54k | 244.77 | |
| Genmab A/s Sponsored Ads (GMAB) | 7.5 | $12M | 431k | 27.47 | |
| Celldex Therapeutics Com New (CLDX) | 6.8 | $11M | 288k | 37.21 | |
| Trevi Therapeutics (TRVI) | 6.2 | $9.8M | 524k | 18.65 | |
| Revolution Medicines (RVMD) | 6.0 | $9.6M | 51k | 187.28 | |
| Definium Therapeutics Com Shs (DFTX) | 5.6 | $8.9M | 188k | 47.04 | |
| Vir Biotechnology (VIR) | 5.5 | $8.7M | 854k | 10.19 | |
| Immunovant (IMVT) | 5.1 | $8.0M | 208k | 38.53 | |
| Urogen Pharma (URGN) | 4.4 | $7.0M | 191k | 36.80 | |
| Eliem Therapeutics (CLYM) | 4.3 | $6.8M | 521k | 13.04 | |
| Adlai Nortye Sponsored Ads (ANL) | 4.0 | $6.4M | 553k | 11.50 | |
| Savara (SVRA) | 3.8 | $6.0M | 978k | 6.16 | |
| Maplight Therapeutics (MPLT) | 2.8 | $4.5M | 125k | 35.84 | |
| Oric Pharmaceuticals (ORIC) | 2.8 | $4.4M | 406k | 10.83 | |
| United Therapeutics Corporation (UTHR) | 2.5 | $3.9M | 7.2k | 541.83 | |
| Vaxcyte (PCVX) | 2.5 | $3.9M | 67k | 58.13 | |
| Beone Medicines Sponsored Ads (ONC) | 2.2 | $3.5M | 12k | 284.97 | |
| Cabaletta Bio (CABA) | 2.2 | $3.5M | 1.3M | 2.72 | |
| Zai Lab Adr (ZLAB) | 1.9 | $3.0M | 156k | 19.00 | |
| Sionna Therapeutics (SION) | 1.8 | $2.8M | 63k | 43.99 | |
| Bright Minds Biosciences Com New (DRUG) | 1.3 | $2.1M | 31k | 70.20 | |
| Aclaris Therapeutics (ACRS) | 0.9 | $1.4M | 258k | 5.29 | |
| Cybin Com New (HELP) | 0.9 | $1.4M | 204k | 6.61 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 0.8 | $1.2M | 19k | 63.95 | |
| Roivant Sciences SHS (ROIV) | 0.6 | $907k | 26k | 35.39 | |
| Tonix Pharmaceuticals Hldg C Com New (TNXP) | 0.5 | $812k | 64k | 12.76 | |
| Protara Therapeutics Com Stk (TARA) | 0.3 | $464k | 122k | 3.82 | |
| Faeth Therapeutics Com New (FTH) | 0.2 | $354k | 14k | 25.00 | |
| Boundless Bio (BOLD) | 0.1 | $138k | 55k | 2.50 | |
| Biomea Fusion (BMEA) | 0.1 | $85k | 250k | 0.34 | |
| Vyne Therapeutics (VYNE) | 0.0 | $40k | 61k | 0.65 |
